detecting

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 64/100

   Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population

   ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Nature aging · 2025-06-23 · Biomarkers

   Over 20% of patients with Alzheimer's disease (AD) worldwide are Chinese, although the efficacy of existing blood-based measures of AD biomarkers is largely unknown in Asian cohorts.

   • Biomarkers
2. 69/100

   Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis

   ✓ Peer-reviewed alzhub usefulness score 69 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024-12-23 · Biomarkers

   Our review summarizes the diagnostic accuracy of plasma and cerebrospinal fluid (CSF) phosphorylated tau 217 (p-tau217) in detecting amyloid and tau pathology on positron emission tomography (PET).

   • Diagnosis
   • Biomarkers
3. 62/100

   Exploring the potential of fully automated LUMIPULSE G plasma assays for detecting Alzheimer's disease pathology

   ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's research & therapy · 2024-03-07 · Biomarkers

   Our results show that the measurement of p-Tau181 in plasma has great potential as a non-invasive prognostic screening tool for implementation in a clinical setting.

   • Biomarkers
   • Diagnosis
   • Early Stage
4. 64/100

   Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform

   ✓ Peer-reviewed alzhub usefulness score 64 out of 100. The journal of prevention of Alzheimer's disease · 2024-01-01 · Biomarkers

   Plasma p-tau217 measured using the Lumipulse platform shows promise as an accurate biomarker of preclinical AD pathology.

   • Biomarkers
   • Early Stage
   • Diagnosis
5. 41/100

   Highly sensitive/selective 3D nanostructured immunoparticle-based interface on a multichannel sensor array for detecting amyloid-beta in Alzheimer's disease

   ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Theranostics · 2018-07-30 · Biomarkers

   This nanostructured conductive interface favors penetration of water-soluble biomolecules and catalyzes a redox reaction, providing limits of detection (LOD) of 6.63 pg/mL for Aβ 40 and 3.74 pg/mL for Aβ 42 .

   • Brain Biology

All topic tags with their study counts